Tarsons Products Limited has informed the Exchange regarding Resignation of Mr Suresh Eshwara Prabhala as Non-Executive Nominee Director of the company w.e.f. August 04, 2025.
TARSONS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tarsons Products Limited announced multiple board changes effective August 4, 2025. The company's investor, Clear Vision Investment Holdings Pte Ltd, replaced its nominee director — Mr. Suresh Eshwara Prabhala stepped down as Non-Executive Nominee Director due to personal reasons, and was simultaneously re-appointed in a different capacity as Non-Executive Non-Independent Director. Clear Vision put forward Mr. Ramanathan Subramanian Arun Kumar (ex-CFO of Bahrain's sovereign wealth fund, with three decades of financial services experience) as its new nominee director. Additionally, Dr. Monjori Mitra, a pediatrician with 24 years of experience, was appointed as a Non-Executive Independent Director for a five-year term. All three appointments are subject to shareholder approval.
This is largely a routine board reshuffle with continuity preserved — Mr. Prabhala remains on the board in a new capacity, so there is no real departure. The addition of an experienced finance professional as the investor's nominee and a new independent director are neutral to mildly positive governance signals, with no material impact expected on the stock price.